Sci-Tech Today Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today Bhutan.

Press releases published on September 9, 2026

15 minutes ago

Kane Biotech to Host Commercial Update Webcast on September 16

Indeterminate GlobeNewswire

17 minutes ago

Bilibili Inc. Announces Completion of US$500 Million Marketed Convertible Senior Notes Offering, Concurrent Equity Placement and Concurrent Delta Repurchase

Indeterminate GlobeNewswire

20 minutes ago

Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

20 minutes ago

Remix Therapeutics Appoints Nicole Sweeny as Chief Commercial Officer

Indeterminate GlobeNewswire

20 minutes ago

Accumulus Technologies Announces Acquisition by Eir Partners to Accelerate Next Phase of Growth

Indeterminate GlobeNewswire

20 minutes ago

Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247

Indeterminate GlobeNewswire

20 minutes ago

SailPoint Announces Fiscal Second Quarter 2027 Results

Indeterminate GlobeNewswire

20 minutes ago

Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)

Indeterminate GlobeNewswire

20 minutes ago

Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes

Indeterminate GlobeNewswire

20 minutes ago

Solstice Oncology Launches with $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy

Indeterminate GlobeNewswire

20 minutes ago

Beeline Medicines Announces Positive Topline Results from Global Phase 2 Study of Afimetoran in Systemic Lupus Erythematosus

Indeterminate GlobeNewswire

20 minutes ago

Xanadu and ASML Announce Collaboration to Advance Lithography for Photonic Quantum Hardware

Indeterminate GlobeNewswire

20 minutes ago

Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Indeterminate GlobeNewswire

20 minutes ago

Broncos Country, This One’s for You: Breckenridge Distillery Kicks Off Another Season with the Denver Broncos and a Limited-Edition Whiskey Collection Honoring “The Drive”

Indeterminate GlobeNewswire

20 minutes ago

Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society

Indeterminate GlobeNewswire

20 minutes ago

Actuate Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with RAS Inhibitors Zoldonrasib and Daraxonrasib

Indeterminate GlobeNewswire

20 minutes ago

Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027

Indeterminate GlobeNewswire

20 minutes ago

MapLight Therapeutics to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

20 minutes ago

ODDITY Tech Reports Second Quarter 2026 Results, Expects Sequential Revenue Improvement in the Third Quarter

Indeterminate GlobeNewswire

20 minutes ago

Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)

Indeterminate GlobeNewswire